-
The objective of this study was to prospectively evaluate the oxygenation effect of inhaled nitric oxide (iNO) delivered during high-frequency oscillatory ventilation (HFOV) in patients with the acute respiratory distress syndrome (ARDS).
-
Alvan Barach, who pioneered the clinical use of oxygen, was also the first investigator to treat acute asthma by having the patient breathe a mixture of helium and oxygen. In 4 adult asthmatics, Barach demonstrated a reduction in dyspnea after just a few breaths of the helium-oxygen mixture, now known as heliox.
-
Nine years ago, muhlenberg regional medical Center in Plainfield, NJ, opened Progressive Care, an intermediate critical care floor to serve patients with diagnoses and conditions that qualify them for ICU care but who dont require the full, intensive nursing and monitoring that an ICU traditionally provides. The system has worked so well that the facility has added a second such flexible unit.
-
-
In this large, randomized trial, critically ill patients who received weekly doses of recombinant human erythropoietin had higher hemoglobin levels and required fewer transfusions than placebo-treated patients.
-
Nationally, its estimated that patients need the services of 30,000 intensivists. since only about 6,000 board-certified intensivists are available, theres a big gap to be filled, and one company offering online clinical services has started filling it.
-
-
In one of the more bizarre stories of the year, the FDA has uncovered files of counterfeit Procrit (epoetin alfaJohnson & Johnson) in routine surveillance. To make matters worse, the fake vials have been contaminated with bacteria and many contain no active ingredient.
-
Since late February 2003, the CDC and WHO have been investigating a multicountry outbreak of an atypical pneumonia manifested by an illness referred to as severe acute respiratory syndrome (SARS). These initial reports in MMWR describe the scope of the outbreak, case definition, and interim infection control guidance for the United States.
-
Repeated injections of a monoclonal anti-IgE antibody markedly decreased the sensitivity of peanut-allergic patients to subsequent peanut exposure. Since fatal anaphylaxis to peanuts can occur following inadvertent ingestion of small amounts of peanut antigen, this treatment might be very useful for peanut-allergic travelers who will be exposed to foods of uncertain purity.
